Twenty-four of 58 adults (41%) and 29 of 56 children (52%) had a BICR-confirmed objective response during the 24-cycle treatment phase; in addition, two adults and one child had confirmed responses ...

FIVE years ago Crystal Rhoden discovered a small bump on her neck that was later found to be neurofibroma, an earth-shattering diagnosis that has been treated with two failed surgical procedures, ...

Healx has secured the US Food and Drug Administration (FDA) clearance for an investigational new drug application (IND) to commence a Phase II clinical trial of HLX-1502, targeting adults with ...

This page lists all known medications that could potentially lead to 'Neurofibroma' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...

CHICAGO -- Selumetinib (Koselugo) significantly improved response rates in adults with neurofibromatosis type 1 (NF1) and symptomatic, inoperable plexiform neurofibromas, the phase III KOMET trial ...

Neurogenic tumour of the nasal cavity is a rare entity and it is rarer still for it to present with visual problem. We like to report a rare case of solitary nasal neurofibroma, which came to light ...

Neurofibromatosis Type 1 (NF1) is an autosomal dominant disorder that commonly presents with ophthalmic lesions. 1 We would like to present a case of a patient with previously undiagnosed NF1 ...

Researchers conducting a preclinical study in mice successfully used targeted molecular therapy to block mostly untreatable nerve tumors that develop in people with the genetic disorder ...

Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Plexiform Neurofibroma Market - A Global and Regional Analysis: Focus on Country and Region, 2025-2035" has been added to ResearchAndMarkets.com's ...

PRIMARY tumors of the diaphragm are rare, less than 40 cases having been reported in the literature. In 1949 Clagett and Johnson 1 analyzed reports of 30 cases of diaphragmatic tumor and, when ...

Erratum: Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: ...